13F reference period
n/a
Security Snapshot
AgomAb Therapeutics NV - Common Shares, no nominal value per share Institutional Ownership
CUSIP: JYH220000
13F Institutional Holders and Ownership History
Institutions Reporting
Shares (Excl. Options)
Price
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, no nominal value per share
- Shares outstanding
- 48,855,821
Filing notes and source
Key facts
- JYH220000 - AgomAb Therapeutics NV - Common Shares, no nominal value per share is tracked under CUSIP JYH220000.
- 13F reference-period holder data is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder data for the Q2 2026 reference period is not available.
- Available periods remain in the history table; they do not substitute for the headline period.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
JYH220000
13F reference period
n/a
13F holders
13D/G owners
3
CIK / CUSIP context first
JYH220000 full holder history
AgomAb Therapeutics NV SEC filings
AgomAb Therapeutics NV company facts
AgomAb Therapeutics NV insider transactions
Broader feeds
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
JYH220000
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10% | 4,873,680 | FMR LLC | 27 Feb 2026 | ||||
| Pontifax Management 4 G.P. (2015) Ltd. | 6.8% | 3,305,846 | Pontifax VI G.P. L.P. | 31 Mar 2026 | ||||
| Redmile Group, LLC | 5.6% | 2,735,926 | Redmile Group, LLC | 31 Mar 2026 |